VELOCIVAX Trademark

Trademark Overview

On Wednesday, March 12, 2025, a trademark application was filed for VELOCIVAX with the United States Patent and Trademark Office. The USPTO has given the VELOCIVAX trademark a serial number of 99080151. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, July 18, 2025. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The VELOCIVAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research services, namely, nucleic acid molecule development and nucleic acid molecule delivery development and production; genetic engineering services utilizing a collection of genetic technologies for the production and delivery of immune modulators; scientific, laboratory and medical research in the field of genetic engineering technologies; scientific laboratories performing nucleic acid molecule development and nucleic acid molecule delivery development; scientific research and development, namely, development of nucleic acid molecule and nucleic acid molecule delivery for others
velocivax

General Information

Serial Number99080151
Word MarkVELOCIVAX
Filing DateWednesday, March 12, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateFriday, July 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical research services, namely, nucleic acid molecule development and nucleic acid molecule delivery development and production; genetic engineering services utilizing a collection of genetic technologies for the production and delivery of immune modulators; scientific, laboratory and medical research in the field of genetic engineering technologies; scientific laboratories performing nucleic acid molecule development and nucleic acid molecule delivery development; scientific research and development, namely, development of nucleic acid molecule and nucleic acid molecule delivery for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 12, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Wednesday, March 12, 2025NEW APPLICATION ENTERED
Wednesday, March 12, 2025APPLICATION FILING RECEIPT MAILED
Thursday, July 10, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 15, 2025ASSIGNED TO EXAMINER

Related Keywords

velocivax molecule development acid nucleic delivery research scientific genetic technologies engineering